Venetoclax-Based Combinations in Acute Myeloid Leukemia: Current Evidence and Future Directions
Sign Up to like & getrecommendations! Published in 2020 at "Frontiers in Oncology"
DOI: 10.3389/fonc.2020.562558
Abstract: The past decade has witnessed major advances in our understanding of molecular biology, which led to breakthrough novel therapies, importantly including the B-cell lymphoma-2 (BCL-2) inhibitor venetoclax. Notably, venetoclax-based combinations have improved outcomes, including both… read more here.
Keywords: venetoclax based; myeloid leukemia; combinations acute; acute myeloid ... See more keywords